Contact
Header_1077x260px_About_Profil.jpg

Do-It-Yourself Artificial Pancreas systems (DIY APS)

Targeting the incretin/glucagon system: a glimmer of hope

Even moderate overweight increases the risk for cardiovascular disease, recent study says

Diabetes: A paradigm case for rewarding innovation in value-based healthcare

Gut Microbiota and Type 2 Diabetes

CGM in pregnant women with type 1 diabetes

Smart ideas for noninvasive glucose monitoring

SUSTAIN 7 - Semaglutide is superior to Dulaglutide

D4kids: Profil joined a new pan-European Artificial Pancreas initiative

Cardiovascular outcome trials of incretin drugs: what have we learned?